跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
沃士韦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
Approved
化学药品
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Dec 18, 2019
Approval ID
7uciym6toNb
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
7uciym6toNb
Approval Number
H20190061
Generic Name
索磷维伏片
Generic Name En
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
Trade Name
沃士韦
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含400mg索磷布韦、100mg维帕他韦和100mg伏西瑞韦
Reg Date
2019-12-18
Expired Date
2024-12-17
Company Name
GILEAD SCIENCES IRELAND UC
Company Address
Carrigtohill, County Cork, T45 DP77, Ireland
Production Company Name
GILEAD SCIENCES IRELAND UC
Production Company Address
IDA Business and Technology Park, Carrigtohill, Co. Cork, Ireland
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/gilead-sciences-ireland-uc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 18, 2019
Approval ID
7uciym6toNb
Type
化学药品
Back to NMPA Approvals